• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Compliance (OC) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 20128590
Nov 20128596
Dec 20128595
Jan 20138583
Feb 20138594
Mar 20138598
Apr 20138586
May 20138586
Jun 20138590
Jul 20138583
Aug 20138593
Sep 20138590

FY 2013 Overall: 91%

Number of OC intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A205
Nov 2012N/A225
Dec 2012N/A160
Jan 2013N/A125
Feb 2013N/A146
Mar 2013N/A198
Apr 2013N/A150
May 2013N/A144
Jun 2013N/A170
Jul 2013N/A137
Aug 2013N/A125
Sep 2013N/A101

FY 2013 Total: 1,891

Total number of OC intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A227
Nov 2012N/A234
Dec 2012N/A169
Jan 2013N/A150
Feb 2013N/A156
Mar 2013N/A203
Apr 2013N/A175
May 2013N/A166
Jun 2013N/A188
Jul 2013N/A166
Aug 2013N/A134
Sep 2013N/A112

FY 2013 Total: 2,088

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.